Northern Peptide Collective Research Library
VIP Research
Vasoactive intestinal peptide (VIP) is an endogenous 28-amino-acid neuropeptide with established roles in neural, gastrointestinal, vascular and immune physiology.
Compound overview
What is VIP?
Vasoactive intestinal peptide (VIP) is an endogenous 28-amino-acid neuropeptide with established roles in neural, gastrointestinal, vascular and immune physiology.
Research covers VPAC receptor signaling, smooth-muscle and vascular biology, neuroimmune communication and pulmonary or gastrointestinal physiology. It should be distinguished from synthetic analogs and related PACAP peptides.
Research themes
VIP research focus
These are literature-navigation themes, not therapeutic claims. Review primary sources for model, methods, formulation, route, endpoints, sample size and limitations.
Independent literature
Researching VIP
Use primary scientific databases as the starting point. Search results can contain studies using different analogs, salts, formulations or experimental models, so confirm molecular identity before comparing outcomes.
Separate cell and animal models from human trials. Note whether a study is exploratory, randomized, controlled, blinded, replicated or peer reviewed. For investigational compounds, regulatory status should remain explicit.
NPC catalogue
VIP research material
No direct NPC catalogue product is mapped to this research hub right now. Use catalogue search to check current availability and product naming.
Search VIP in catalogueAnalytical documentation
VIP quality, testing & COAs
For research materials, batch-specific documentation is more useful than a generic purity statement. Confirm that analytical documentation identifies the material, lot or batch and test methods used.
Frequently asked questions
VIP FAQ
What is VIP?
Vasoactive intestinal peptide (VIP) is an endogenous 28-amino-acid neuropeptide with established roles in neural, gastrointestinal, vascular and immune physiology.
What research areas are associated with VIP?
Research covers VPAC receptor signaling, smooth-muscle and vascular biology, neuroimmune communication and pulmonary or gastrointestinal physiology. It should be distinguished from synthetic analogs and related PACAP peptides.
How strong is the evidence for VIP?
The evidence context for this hub is: Established physiology and clinical research literature. Review primary sources and distinguish preclinical models from human clinical research.
Where can I find independent VIP research?
Use PubMed, ClinicalTrials.gov where relevant, journal databases and the references within peer-reviewed review articles. Search by both the compound name and known aliases.
How do I verify an NPC VIP batch?
Use NPC's COA Verification resources and match documentation to the exact product lot where batch-specific records are available.
Does this page provide dosing or medical guidance?
No. Northern Peptide Collective products and this research library are for research purposes only and are not intended for human consumption or medical use.